Korea / Special Situations, Clepsydra Capital

Sanghyun Park

I investigate special situations in Korea.

Korea / Special Situations

Samsung BioLogics IPO Part 1 - IPO Proceeding

Samsung BioLogics IPO Part 2 - Financials

Equity Capital Markets

Samsung Biologics   / Equity Capital Markets

<p>In a regulatory filing (last Friday), Samsung Biologics announced its plan to raise ₩1.23tril (US$1.12bil) of new shares. Samsung BioLogics plans to sell a total of 11,027,558 new shares priced at ₩113,000. The company's initially expected IPO price band was ₩113,000 - ₩136,000. So, this is like Samsung BioLogics chose the lower end of its expected price band. 11,027,558 new shares is about 20% of its total shares. In addition, Samsung BioLogics' shareholder Samsung Electronics is planning to…</p>

In a regulatory filing (last Friday), Samsung Biologics announced its plan to raise ₩1.23tril (US$1.12bil) of new shares. Samsung BioLogics plans to sell a total of 11,027,558 new shares priced at ₩113,000. The company's initially expected IPO price band was ₩113,000 - ₩136,000. So, this is like Samsung BioLogics chose the lower end of its expected price band. 11,027,558 new shares is about 20% of its total shares. In addition, Samsung BioLogics' shareholder Samsung Electronics is planning to…

TSMC (Taiwan Semiconductor Manufacturing) (2330 TT)

TSMC (Taiwan Semiconductor Manufacturing)

Samsung BioLogics IPO Price, Capital Investment Plan & Valuation Issue